Literature DB >> 22959272

Hepatic expression of HCV RNA-dependent RNA polymerase triggers innate immune signaling and cytokine production.

Guann-Yi Yu1, Guobin He, Chia-Yang Li, Martin Tang, Sergei Grivennikov, Wan-Ting Tsai, Ming-Sian Wu, Chih-Wen Hsu, Yu Tsai, Lily Hui-Ching Wang, Michael Karin.   

Abstract

Innate immunity controls pathogen replication and spread. Yet, certain pathogens, such as Hepatitis C Virus (HCV), escape immune elimination and establish persistent infections that promote chronic inflammation and related diseases. Whereas HCV regulatory proteins that attenuate antiviral responses are known, those that promote inflammation and liver injury remain to be identified. Here, we show that transient expression of HCV RNA-dependent RNA polymerase (RdRp), NS5B, in mouse liver and human hepatocytes results in production of small RNA species that activate innate immune signaling via TBK1-IRF3 and NF-κB and induce cytokine production, including type I interferons (IFN) and IL-6. NS5B-expression also results in liver damage.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22959272      PMCID: PMC3483424          DOI: 10.1016/j.molcel.2012.07.032

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  22 in total

Review 1.  Hepatitis C virus infection.

Authors:  G M Lauer; B D Walker
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

Review 2.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 3.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

4.  Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.

Authors:  Hans Häcker; Vanessa Redecke; Blagoy Blagoev; Irina Kratchmarova; Li-Chung Hsu; Gang G Wang; Mark P Kamps; Eyal Raz; Hermann Wagner; Georg Häcker; Matthias Mann; Michael Karin
Journal:  Nature       Date:  2005-11-23       Impact factor: 49.962

5.  Effect of alpha interferon on the hepatitis C virus replicon.

Authors:  J T Guo; V V Bichko; C Seeger
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 6.  Inflammation meets cancer, with NF-κB as the matchmaker.

Authors:  Yinon Ben-Neriah; Michael Karin
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

7.  Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA.

Authors:  Takeshi Saito; David M Owen; Fuguo Jiang; Joseph Marcotrigiano; Michael Gale
Journal:  Nature       Date:  2008-06-11       Impact factor: 49.962

8.  Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences.

Authors:  Hayato Nakagawa; Shin Maeda; Haruhiko Yoshida; Ryosuke Tateishi; Ryota Masuzaki; Takamasa Ohki; Yoku Hayakawa; Hiroto Kinoshita; Minoru Yamakado; Naoya Kato; Shuichiro Shiina; Masao Omata
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

9.  Functional role of type I and type II interferons in antiviral defense.

Authors:  U Müller; U Steinhoff; L F Reis; S Hemmi; J Pavlovic; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

10.  Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomes.

Authors:  Kazuhito Naka; Hiromichi Dansako; Naoya Kobayashi; Masanori Ikeda; Nobuyuki Kato
Journal:  Virology       Date:  2005-12-02       Impact factor: 3.616

View more
  30 in total

1.  The Mammalian response to virus infection is independent of small RNA silencing.

Authors:  Simone Backes; Ryan A Langlois; Sonja Schmid; Andrew Varble; Jaehee V Shim; David Sachs; Benjamin R tenOever
Journal:  Cell Rep       Date:  2014-06-19       Impact factor: 9.423

Review 2.  Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.

Authors:  Amir Shlomai; Ype P de Jong; Charles M Rice
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

3.  The Coding Region of the HCV Genome Contains a Network of Regulatory RNA Structures.

Authors:  Nathan Pirakitikulr; Andrew Kohlway; Brett D Lindenbach; Anna M Pyle
Journal:  Mol Cell       Date:  2016-02-25       Impact factor: 17.970

4.  Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit.

Authors:  Zehua Zhu; Amir R Aref; Travis J Cohoon; Thanh U Barbie; Yu Imamura; Shenghong Yang; Susan E Moody; Rhine R Shen; Anna C Schinzel; Tran C Thai; Jacob B Reibel; Pablo Tamayo; Jason T Godfrey; Zhi Rong Qian; Asher N Page; Karolina Maciag; Edmond M Chan; Whitney Silkworth; Mary T Labowsky; Lior Rozhansky; Jill P Mesirov; William E Gillanders; Shuji Ogino; Nir Hacohen; Suzanne Gaudet; Michael J Eck; Jeffrey A Engelman; Ryan B Corcoran; Kwok-Kin Wong; William C Hahn; David A Barbie
Journal:  Cancer Discov       Date:  2014-01-20       Impact factor: 39.397

Review 5.  The oncologic burden of hepatitis C virus infection: A clinical perspective.

Authors:  Harrys A Torres; Terri Lynn Shigle; Nassim Hammoudi; James T Link; Felipe Samaniego; Ahmed Kaseb; Vincent Mallet
Journal:  CA Cancer J Clin       Date:  2017-07-06       Impact factor: 508.702

6.  Mycotoxin Patulin Suppresses Innate Immune Responses by Mitochondrial Dysfunction and p62/Sequestosome-1-dependent Mitophagy.

Authors:  Wan-Ting Tsai; Yin-Chiu Lo; Ming-Sian Wu; Chia-Yang Li; Yi-Ping Kuo; Yi-Hui Lai; Yu Tsai; Kai-Chieh Chen; Tsung-Hsien Chuang; Chun-Hsu Yao; Jinq-Chyi Lee; Li-Chung Hsu; John T-A Hsu; Guann-Yi Yu
Journal:  J Biol Chem       Date:  2016-07-25       Impact factor: 5.157

7.  Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells.

Authors:  Hironori Nishitsuji; Kenji Funami; Yuko Shimizu; Saneyuki Ujino; Kazuo Sugiyama; Tsukasa Seya; Hiroshi Takaku; Kunitada Shimotohno
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

8.  Activation of the RLR/MAVS Signaling Pathway by the L Protein of Mopeia Virus.

Authors:  Lei-Ke Zhang; Qi-Lin Xin; Sheng-Lin Zhu; Wei-Wei Wan; Wei Wang; Gengfu Xiao
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

9.  Engineered Mammalian RNAi Can Elicit Antiviral Protection that Negates the Requirement for the Interferon Response.

Authors:  Asiel Arturo Benitez; Laura Adrienne Spanko; Mehdi Bouhaddou; David Sachs; Benjamin Robert tenOever
Journal:  Cell Rep       Date:  2015-11-05       Impact factor: 9.423

Review 10.  Hepatitis C Virus Replication.

Authors:  Keisuke Tabata; Christopher J Neufeldt; Ralf Bartenschlager
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.